Director, Global Medical Affairs, Lung

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RASaddicted cancers. The companys R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity Reporting to the Lung Cancer Medical Affairs Strategy Lead, the Director, Global Medical Affairs will be responsible for supporting the development and execution of the Global Medical Affairs (GMA) strategy and tactical plans for Revolution Medicines assets being developed for the treatment of lung cancer. The successful candidate will have a proven track record of developing and driving medical strategy with a focus on effectively communicating key scientific data through publications, medical information, medical communications, congress activities as well as gathering insights through advisory boards and Key Opinion Leader (KOL) engagements. Key responsibilities Develops and executes the GMA strategy and medical objectives including activities related to scientific engagement and communication, evidence generation, internal education, and patient advocacy. Develops and executes a Health Care Professional (HCP) engagement strategy to gather insights to shape internal programs. Acts as the medical representative on crossfunctional teams Serves as a therapeutic area content expert. Participates in the Global Medical Affairs Team (GMAT) to execute medical strategies, contribute to the operations and oversight of medical activities, and work crossfunctionally to support associated prelaunch activities. Supports the execution of routine gap assessments leading to the development/refinement of a publication strategy, an evidence generation plan, and tactical plan as part of the overall GMA plan. Provides medical leadership in scientific engagement activities with key external stakeholders through organizing and leading advisory boards, studies investigator interactions, congress activities, and peertopeer discussions with the goal of communicating scientific insights to internal teams to drive strategy. Communicates clinical and scientific data to KOLs and other healthcare professionals through presentations, educational programmes, and scientific discussions. Represents various medical affairs functions in crossfunctional strategy team meetings including Clinical and Safety subteams, Global Brand Team, Global Product Team, Patient Advocacy, Market Access, and other crossfunctional strategic discussions. Works closely with the Clinical and MSL teams to provide enrollment, scientific, and engagement support to ensure clinical trials meet study timelines. Partners with RWE strategy and Biomarker/CDx teams on related integrated evidence generation strategies and activities as part of the GMA Plan. Works with the Patient Advocacy and Grants teams to incorporate the patient voice and define external medical education strategies for independent grants, respectively. Provides medical support for scientific symposia and medical congresses and collaborate across GMA functions to develop, review, and align on key scientific communication points and medical information response documents within legal and compliance guidelines. Supports the review and approval of abstracts, manuscripts, corporate communications, and other data disclosure documents as well as internal stakeholder medical education activities related to the compound data and related competitor data. Collaborates with stakeholders across the organization, including, but not limited to, Clinical Development and Operations, Commercial Operations, Program Management, Business Development, Regulatory, Safety, and Compliance teams. Required Skills, Experience and Education An advanced doctorate degree (PharmD, PhD, MD, DO or equivalent) in medical/scientific area is required. 10+ years of relevant experience in the biotech or pharmaceutical industry focused on Medical Affairs, with global crossfunctional inhouse experience and on fieldbased teams. Must have a strong scientific background in lung cancer with a good understanding of biomarkerdriven disease and ability to effectively analyze, synthesize and communicate complex scientific information. Direct, handson experience executing the activities of various functions within medical affairs (training, medical communications, medical information, expanded access programmes, evidence generation, publications). Proven track record of clinical trial support including protocol development/review, site selection support, enrolment support, and data analysis. Excellent interpersonal, written, and presentation skills with the ability to effectively communicate complex scientific data with a strong point of view to diverse audiences. Thrives in fastpaced, dynamic environment and ability to multitask independently with limited supervision. Ability to travel to Redwood City headquarters and professional congresses (30 - 40%). Strong networking skills with deep existing relationships with lung cancer healthcare professionals including global top key opinion leaders required. Preferred Skills Experience in global product launches including support of integrated brand plan ideation, regulatory submissions, reimbursement, and label development. Experience in guideline submissions (e.g. NCCN) and engagements with global health authorities preferred. #LI-Hybrid #LI-VN1#J-18808-Ljbffr